Osaic Holdings
RANI icon

Osaic Holdings’s Rani Therapeutics RANI Stock Holding History

Osaic Holdings’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$1.35K – 8020
2025
Q4 		$1.35K Hold
1,000
– – ﹤0.01% 7192
2025
Q3 		$490 Sell
1,000
-5,668
-85% -$2.95K ﹤0.01% 7552
2025
Q2 		$3.4K Hold
6,668
– – ﹤0.01% 6742
2025
Q1 		$8.4K Buy
6,668
+5,168
+345% +$7.65K ﹤0.01% 5884
2024
Q4 		$2.06K Buy
+1,500
New +$3.15K ﹤0.01% 6590
2022
Q3 		– Sell
-19,012
Closed -$196K – 7461
2022
Q2 		$196K Sell
19,012
-331
-2% -$3.8K ﹤0.01% 3818
2022
Q1 		$261K Sell
19,343
-1,729
-8% -$28.7K ﹤0.01% 3797
2021
Q4 		$344K Buy
+21,072
New +$479K ﹤0.01% 3426

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Osaic Holdings's RANI Position: Q1 2026 in Review

Osaic Holdings sold out of Rani Therapeutics (RANI) in Q1 2026, closing a stake of 1,000 shares — an estimated $1.35K sold.

Osaic Holdings first reported a position in RANI in Q4 2021 and held it in 8 quarters. The position peaked at $344K in Q4 2021. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Osaic Holdings reported no remaining Rani Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 1,000 Rani Therapeutics shares in Q1 2026, an estimated $1.35K.
  • Osaic Holdings first reported a position in Rani Therapeutics in Q4 2021 and held it in 8 quarters.
  • Osaic Holdings's Rani Therapeutics position peaked at $344K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.